Fast, flexible and proven, IQVIA’s industry-leading electronic clinical outcome assessment (eCOA) platform ramps up efficiencies, delivers real-time data, and sharpens insights through best-in-class technology and a better patient experience.
Case Study
Transforming Oncology Research: IQVIA’s End-to-End Patient Experience Data Approach
Scientific expertise and technology converge to deliver end-to-end, fit-for-purpose, regulator-ready patient experience data
Feb 18, 2026
Explore how an end‑to‑end, patient‑focused data approach is helping oncology trials meet evolving FDA expectations while capturing meaningful patient experience data. This case study highlights how combining COA science, oncology‑specific eCOA capabilities, and real‑time data visibility enables sponsors to reduce patient burden, improve compliance, and generate regulator‑ready outcomes across complex oncology studies.
You may also be interested in
Blog
eCOA in Rheumatoid Arthritis Clinical Trials: Driving Data Accuracy, Patient Experience and Trial Outcomes
eCOAs support key study endpoints while enhancing site and patient experience
Related solutions
eCOA
Patient Engagement Suite
Technology informed by unparalleled Decentralized Trials (DCT) operational experience and delivered at global scale.
Connected Devices
Clinical trials face increasing pressure to deliver new treatments to market faster. IQVIA Connected Devices accelerates trial outcomes with medical device recommendations that fit your clinical study, deliver cleaner data, and speed data collection and analysis with lower patient and site burdens.
